The Inhibition of SARS-CoV-2 and the Modulation of Inflammatory Responses by the Extract of <i>Lactobacillus sakei</i> Probio65
In the three years since the first outbreak of COVID-19 in 2019, the SARS-CoV-2 virus has continued to be prevalent in our community. It is believed that the virus will remain present, and be transmitted at a predictable rate, turning endemic. A major challenge that leads to this is the constant yet...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2022-12-01
|
| Col·lecció: | Vaccines |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2076-393X/10/12/2106 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|